Media coverage about Adeptus Health (NYSE:ADPT) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Adeptus Health earned a coverage optimism score of 0.04 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 44.6492874193702 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Adeptus Health (NYSE ADPT) opened at 1.41 on Friday. Adeptus Health has a 1-year low of $0.90 and a 1-year high of $73.44. The firm’s 50-day moving average price is $1.82 and its 200 day moving average price is $11.06.

WARNING: This piece was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/08/11/adeptus-health-nyseadpt-given-coverage-optimism-score-of-0-04.html.

About Adeptus Health

Adeptus Health Inc is a patient-centered healthcare company. The Company is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. The Company has approximately 80 freestanding facilities and over two licensed general hospitals.

Insider Buying and Selling by Quarter for Adeptus Health (NYSE:ADPT)

Receive News & Ratings for Adeptus Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adeptus Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.